-
Kim RB. Drugs as P-glycoprotein substrates, inhibitors and inducers. Drug Metab Rev. 2002; 34(1-2):47-54.
-
Yu DK. The contribution of P-glycoprotein to pharmacokinetic drug-drug interactions. J Clin Pharmacol. 1999;39(12):1203-1211.
-
West CL, Mealey KL. Assessment of antiepileptic drugs as substrates for canine P-glycoprotein. Am J Vet Res. 2007;68(10):1106-1110.
-
Barbet JL, Snook T, Gay JM, Mealey KL. ABCB1-1 (MDR1-1) genotype is associated with adverse reactions in dogs treated with milbemycin oxime for generalized demodicosis. Vet Dermatol. 2009;20(2):111-114.
-
Mealey KL, Fidel J, Gay JM, Impellizeri JA, Clifford CA, Bergman PJ. ABCB1-1 polymorphism can predict hematologic toxicity in dogs treated with vincristine. JVIM. 2008;22(4):996-1000.
-
Mealey KL, Bentjen SA, Gay JM, Cantor GH. Ivermectin sensitivity in collies is associated with a deletion mutation of the MDR1 gene. Pharmacogenetics. 2001;11(8):727-733.
-
Mealey KL, Burke NS. Identification of a nonsense mutation in feline ABCB1. J Vet Pharmacol Ther. 2015;38(5):429-433.
-
Wright HM, Chen AV, Talcott PA, Poppenga RH, Mealey KL. Intravenous fat emulsion as treatment for ivermectin toxicosis in three dogs homozygous for the ABCB1-1 gene mutation. J Vet Emerg Crit Care (San Antonio). 2011;21(6): 666-672.
-
Krugman L, Bryan JN, Mealey KL, Chen A. Vincristine-induced central neurotoxicity in a collie homozygous for the ABCB1 mutation. J Small Anim Pract. 2012;53(3):185-187.
-
Mealey KL, Greene S, Bagley R, et al. P-glycoprotein contributes to the blood-brain, but not blood-cerebrospinal fluid, barrier in a spontaneous canine P-glycoprotien knockout model. Drug Metab Dispos. 2008;36(6):1073-1079.
-
Deshpande D, Hill KE, Mealey KL, Chambers P, Gieseg MA. The effect of the canine ABCB1-1 mutation on sedation after intravenous administration of acepromazine. JVIM. doi: 10.1111/jvim. 13827.
-
Mealey KL. Unpublished observations, clinical data, and ongoing clinical/laboratory research; small animal medicine and research, Washington State University; accumulated clinical/laboratory evidence as of November 2015.
-
Mealey KL, Barhoumi R, Burhhardt RC, Safe S, Kochevar DT. Doxycycline induces expression of P-glycoprotein in MCF-7 breast carcinoma cells. Antimicrob Agents Chemother. 2002;46(3):755-761.
-
Plumb DC. Emodepside + praziquantel. In: Plumb DC, ed. Plumbs Veterinary Drug Handbook. 8th ed. Ames, IA: Wiley-Blackwell; 2015:505-507.
-
Elmshuser S, Straehle LC, Kranz J, Krebber R, Geyer J. Brain penetration of emodepside is increased in P-glycoprotein-deficient mice and leads to neurotoxicosis. J Vet Pharmacol Ther. 2015; 38(1):74-79.
-
Hugnet C, Pineau X. Emodepside sensitivity in German shepherd dog is associated with deletion mutation of the MDR1 gene. In: Proceedings of 22nd ECVIM-CA Congress. 2012; Maastricht, Netherlands.
-
Nelson OL, Carsten E, Bentjen SA, Mealey KL. Ivermectin toxicity in an Australian shepherd dog with the MDR1 mutation associated with ivermectin sensitivity in collies. JVIM. 2003;17(3): 354-356.
-
Mealey KL, Northrup NC, Bentjen SA. Increased toxicity of P-glycoprotein-substrate chemotherapeutic agents in a dog with the MDR1 deletion mutation associated with ivermectin sensitivity. JAVMA. 2003;223(10):1453-1455.
-
Plumb DC. Paclitaxel. In: Plumb DC, ed. Plumb's Veterinary Drug Handbook. 8th ed. Ames, IA: Wiley-Blackwell; 2015: 809-810.
-
Sartor LL, Bentjen SA, Trepanier L, Mealey KL. Loperamide toxicity in a collie with the MDR1 mutation associated with ivermectin sensitivity. JVIM. 2004;18(1):117-118.
-
Coelho JC, Tucker R, Mattoon J, Roberts G, Waiting DK, Mealey KL. Biliary excretion of technetium-99m-sestamibi in wild-type dogs and in dogs with intrinsic (ABCB1-1 mutation) and extrinsic (ketoconazole treated) P-glycoprotien deficiency. J Vet Pharmacol Ther. 2009;32(5):417-421.
-
Mealey KL, Gay JM, Martin LG, Waiting DK. Comparison of the hypothalamic-pituitary-adrenal axis in MDR1-1 and MDR1 wildtype dogs. JVECC. 2007;17(1):61-66.